Featured Research

from universities, journals, and other organizations

A Friendly Reminder For HIV Patients

Date:
September 15, 2005
Source:
Johns Hopkins Medical Institutions
Summary:
In a study from Johns Hopkins, a pocket-size device giving electronic-voice reminders to "take your medicine" proves to be a success for people living with HIV whose memory is slightly impaired by the virus.

A pocket-size device giving electronic-voice reminders to “take your medicine” proves to be a success for people living with HIV whose memory is slightly impaired by the virus.
Credit: Image courtesy of Johns Hopkins Medical Institutions

In a study from Johns Hopkins, a pocket-size device givingelectronic-voice reminders to "take your medicine" proves to be asuccess for people living with HIV whose memory is slightly impaired bythe virus.

Related Articles


The investigators report that the device, dubbed "Jerry" by mostusers, is a portable gadget programmed to ease the task of takingmedicines in multiple doses every day on time. HIV-infected patients,particularly those suffering from mild memory loss from the disease,benefit highly from Jerry's friendly reminders, according to a studypublished in the Sept. 15 issue of the journal Clinical InfectiousDiseases.

Like an alarm clock, Jerry, more properly known as DiseaseManagement Assistance System (DMAS), flashes a light and verbally tellsthe patient the exact dosage and medication to take at the correcttime. DMAS is rechargeable and weighs about as much as a cell phone.Its computer programming keeps track of the patient's compliance,allowing the doctor to download and print a report for monitoring thepatient's adherence to the medication schedule.

"One of the biggest reasons HIV patients cite for not takingtheir medication is just plain forgetfulness," says Adriana Andrade,M.D., M.P.H., assistant professor at the Johns Hopkins UniversityDivision of Infectious Diseases. "We thought a verbal reminder would bethe best possible solution."

According to Andrade, treating HIV can be a grueling task forpatients who must follow a hectic pill schedule, a combination of drugscalled highly active antiretroviral therapy (HAART). Those who misstheir medication a few times quickly develop a viral resistance to thedrug, a problem since replacement options are few.

"On average, HIV-infected, treatment-naοve patients today takeroughly two pills once a day, a significant decrease from a few yearsago, when patients had to juggle dozens of medications per week," saysAndrade. "But with all the regimens, patients must adhere to theirmedication faithfully because the virus easily develops a resistance,more so than most infectious diseases."

HIV can cause brain damage, making it more difficult for somepatients to remember their HAART regimen, which is often different forevery patient.

"We recruited patients with either normal memory or mild memoryimpairment for the study," says Andrade. "The results indicate thatboth groups adhered to their medication more so than not with Jerry,but the memory-impaired patients showed a greater improvement."

Fifty-eight of 64 patients completed the four-month study. Halfof the patients were given a Jerry device and attended adherencecounseling sessions, while the other half received only counseling.Those with Jerry took their medication 80 percent of the time, whilethose without did so only 65 percent of the time.

Of the 31 memory-impaired patients, those using Jerry had a 77percent adherence rate, while those without Jerry had a 57 percentadherence rate, a 20 percent difference. The remaining patients withnormal memory also adhered more with Jerry, but there was not asignificant variance from those without the device, according to theresearchers.

Throughout the study, all patients were given plasma viral loadtests, which measure the amount of HIV in the blood. However, there wasno significant difference in lessening the HIV amount between thosewith or without Jerry, according to the researchers.

"Hopefully, other devices like the DMAS will be furtherevaluated in similar studies, while incorporating the recenttechnologies of the two-way pager, cell phones or special alarmclocks," says Andrade.

The DMAS used in this study was manufactured by Adherence Technologies.

###

Funding was provided by grants from the National Institutes ofHealth, the Johns Hopkins Hospital General Clinical Research Center andMerck Laboratories.

Other researchers involved in the study were Henraya McGruder,Ph.D.; Albert Wu, M.D., M.P.H.; Shivaun Celano, Pharm.D.; RichardSkolasky Jr., M.A.; Ola Selnes, Ph.D.; I-Chan Huang, Ph.D.; and JustinMcArthur, M.B.B.S., M.P.H.

On the web:http://www.journals.uchicago.edu/CID/journal/rapid.html


Story Source:

The above story is based on materials provided by Johns Hopkins Medical Institutions. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Medical Institutions. "A Friendly Reminder For HIV Patients." ScienceDaily. ScienceDaily, 15 September 2005. <www.sciencedaily.com/releases/2005/09/050915001909.htm>.
Johns Hopkins Medical Institutions. (2005, September 15). A Friendly Reminder For HIV Patients. ScienceDaily. Retrieved October 24, 2014 from www.sciencedaily.com/releases/2005/09/050915001909.htm
Johns Hopkins Medical Institutions. "A Friendly Reminder For HIV Patients." ScienceDaily. www.sciencedaily.com/releases/2005/09/050915001909.htm (accessed October 24, 2014).

Share This



More Health & Medicine News

Friday, October 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) — The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) — An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins